持股变动声明
CARGO Therapeutics(CRGX)03-05 05:25
$CARGO Therapeutics(CRGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000112 Size: 5 KB 网页链接
简介：CARGO Therapeutics, Inc.于2019年12月在特拉华州注册成立，名称为Syncopation Life Sciences, Inc.，并于2022年9月更名为CARGO Therapeutics, Inc.。该公司是一家处于临床阶段的生物技术公司，具有独特的优势，能够为癌症患者推进下一代潜在的治疗细胞疗法。该公司的项目、平台技术和制造战略旨在直接解决已获批准的嵌合抗原受体（CAR）T细胞疗法的局限性。
| 今开：18.46 | 昨收：18.28 |
| 最高：18.86 | 最低：18.265 |
| 涨停价： | 跌停价： |
| 总市值：735406326 |
CARGO Therapeutics(CRGX)03-05 05:25
$CARGO Therapeutics(CRGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000112 Size: 5 KB 网页链接
CARGO Therapeutics(CRGX)03-05 05:35
$CARGO Therapeutics(CRGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000114 Size: 5 KB 网页链接
CARGO Therapeutics(CRGX)02-15 01:45
$CARGO Therapeutics(CRGX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001274173-24-000056 Act: 34 Size: 10 KB 网页链接
CARGO Therapeutics(CRGX)02-14 23:15
$CARGO Therapeutics(CRGX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-24-000780 Act: 34 Size: 6 KB 网页链接
CARGO Therapeutics(CRGX)03-22 04:15
$CARGO Therapeutics(CRGX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-034693 Act: 34 Size: 270 KB 网页链接
CARGO Therapeutics(CRGX)04-18 04:25
$CARGO Therapeutics(CRGX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001610717-24-000208 Size: 10 KB 网页链接
CARGO Therapeutics(CRGX)04-16 04:25
$CARGO Therapeutics(CRGX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-096227 Act: 34 Size: 154 KB 网页链接
CARGO Therapeutics(CRGX)02-15 05:35
$CARGO Therapeutics(CRGX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-036311 Act: 34 Size: 127 KB 网页链接
CARGO Therapeutics(CRGX)03-22 04:55
$CARGO Therapeutics(CRGX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034730 Act: 34 Size: 15 MB 网页链接
CARGO Therapeutics(CRGX)02-09 21:55
$CARGO Therapeutics(CRGX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-001059 Act: 34 Size: 8 KB 网页链接
$CARGO Therapeutics(CRGX)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-110173 Act: 34 Size: 1 MB 网页链接
$CARGO Therapeutics(CRGX)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-110184 Act: 34 Size: 1 MB 网页链接
$CARGO Therapeutics(CRGX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001610717-24-000208 Size: 10 KB 网页链接
$CARGO Therapeutics(CRGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000209 Size: 5 KB 网页链接
$CARGO Therapeutics(CRGX)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-096227 Act: 34 Size: 154 KB 网页链接
$CARGO Therapeutics(CRGX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-074104 Act: 33 Size: 99 KB 网页链接
$CARGO Therapeutics(CRGX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034730 Act: 34 Size: 15 MB 网页链接
$CARGO Therapeutics(CRGX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-034693 Act: 34 Size: 270 KB 网页链接
$CARGO Therapeutics(CRGX)$ 8-K Current report, item 1.01 Accession Number: 0001193125-24-063752 Act: 34 Size: 149 KB 网页链接
$CARGO Therapeutics(CRGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001610717-24-000115 Size: 5 KB 网页链接